Novan
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Novan sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).
Novan: 18 sponsored US clinical trials, none currently recruiting.
Novan sponsors 18 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 18 completed. 6 of these trials are in Phase 3-4 (later-stage) and 12 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Acne Vulgaris, with 3 trials.
Top-decile sponsor footprint
Novan ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
18 of 18 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
18 total, page 1 of 1
A Phase 3 Molluscum Contagiosum Efficacy and Safety Study
NCT04535531
A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC
NCT03927703
A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)
NCT03927716
A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum
NCT03436615
A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis
NCT03431610
A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis
NCT03445013
Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris
NCT02801903
P3 Long Term Safety Study of Once Daily SB204 in Acne
NCT02798120
P3 Study in Acne Comparing Once Daily SB204 and Vehicle
NCT02672332
P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne
NCT02667444
A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204
NCT02581072
Topical NVN1000 for the Treatment of External Genital and Perianal Warts
NCT02462187
P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris
NCT02242760
A Phase 1 Study Assessing Local Cutaneous Effects of SB204
NCT02250430
A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris
NCT02164084
A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel
NCT01844739
A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers
NCT01755247
Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers
NCT01694810
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 9 |
| Phase 2 | 3 |
| Phase 3 | 6 |
Therapeutic Areas
How the Novan early-phase archive is shaped
18 indexed studies, none listed as recruiting (0% open); 18 completed (100%).
Phase mix: 6 late (III/IV) vs 12 early (I/II) (early-phase heavy).
Top condition: Acne Vulgaris (3 trials), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Novan: archived-pipeline peers nationwide
Peers matched on 18 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Novan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 18 archived trials
- ADC Therapeutics S.A. · 18 trials · 11% recruiting
- Akros Pharma · 18 trials · 0% recruiting
- AO Clinical Investigation and Publishing Documentation · 18 trials · 0% recruiting
- AO Innovation Translation Center · 18 trials · 33% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Novan page
18 registered trials is a research-attention snapshot, not an endorsement of Novan or any single study.
- None of Novan's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Acne Vulgaris is the condition Novan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acne Vulgaris trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Novan pipeline card: 18 registered trials from official public datasets.Report a data error.